Anti‐tissue Plasminogen Activator (tPA) as an Effective Therapy of Neonatal Hypoxia–Ischemia with and without Inflammation

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-5949|21|4|367-373

ISSN： 1755-5930

Source： CNS: NEUROSCIENCE AND THERAPEUTICS, Vol.21, Iss.4, 2015-04, pp. : 367-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sexually Dimorphic Outcomes after Neonatal Stroke and Hypoxia-Ischemia

By Charriaut-Marlangue Christiane   Besson Valérie C.   Baud Olivier  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 61-61

MDPI

Access to resources Recommend Favorite

Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia

By Alonso-Alconada Daniel   Álvarez Antonia   Arteaga Olatz   Martínez-Ibargüen Agustín   Hilario Enrique  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-04 ,pp. : 9379-9395

MDPI

Access to resources Recommend Favorite

Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator

By Hoirisch-Clapauch Silvia   Nardi Antonio E.  

International Journal of Molecular Sciences, Vol. 16, Iss. 11, 2015-11 ,pp. : 27550-27560

MDPI

Access to resources Recommend Favorite

Stability of Recombinant Tissue Plasminogen Activator at −30 °C over One Year

By Alkatheri Abdulmalik  

Pharmaceuticals, Vol. 6, Iss. 1, 2013-01 ,pp. : 25-31

MDPI

Access to resources Recommend Favorite

The Zinc Ion Chelating Agent TPEN Attenuates Neuronal Death/apoptosis Caused by Hypoxia/ischemia Via Mediating the Pathophysiological Cascade Including Excitotoxicity, Oxidative Stress, and Inflammation

By  

CNS: NEUROSCIENCE AND THERAPEUTICS, Vol. 21, Iss. 9, 2015-09 ,pp. : 708-717

John Wiley & Sons Inc

Access to resources Recommend Favorite